4 months ago
IRTC
AnalystsDavid RescottDavid Rescott's Stock Forecasts
AnalystsDavid Rescott
Sectors:
Industries:
Analyst Ranking
Top 35%
#1592 out of 4565 analysts
Average Return
+1.19%
Win Rate
43%15 out of 35
Risk vs Reward
Poor
Good
David Rescott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Penumbra IncPEN | +141.93% | $124.98 | $302.36 | 2022-07-20 - 2023-07-19 | Strong Buy |
Si Bone IncSIBN | +65.40% | $12.08 | $19.98 | 2022-12-20 - 2023-12-19 | Strong Buy |
Penumbra IncPEN | +45.36% | $199.65 | $290.22 | 2022-09-13 - 2023-09-12 | Strong Buy |
Boston Scientific CorpBSX | +39.97% | $52.34 | $73.26 | 2023-07-19 - 2024-04-25 | Buy |
Boston Scientific CorpBSX | +35.74% | $53.97 | $73.26 | 2023-09-21 - 2024-04-25 | Buy |
David Rescott Analyst Color
Get additional color on David Rescott's coverage of popular stocks
4 months ago
SIBN
4 months ago
PEN
4 months ago
AXNX
4 months ago
IRTC
a year ago
PEN
a year ago
IRTC
David Rescott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Boston Scientific CorpBSX | 3 | Buy | $84.00 | +14.66% | Maintains | 2 days ago |
Penumbra IncPEN | 13 | Strong Buy | $290.00 | +41.12% | Maintains | 2 months ago |
Axonics IncAXNX | 8 | Hold | $71.00 | +6.70% | Downgrades | 3 months ago |
Irhythm Technologies IncIRTC | 6 | Strong Buy | $133.00 | +19.53% | Maintains | 4 months ago |
Si Bone IncSIBN | 5 | Strong Buy | $26.00 | +82.20% | Maintains | 4 months ago |
Edwards Lifesciences CorpEW | 1 | Buy | $107.00 | +21.58% | Initiates Coverage On | 9 months ago |
Medtronic PLCMDT | 1 | Hold | $90.00 | +13.56% | Initiates Coverage On | 9 months ago |
Inari Medical IncNARI | 1 | Buy | $79.00 | +107.51% | Initiates Coverage On | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.